117 related articles for article (PubMed ID: 8222166)
21. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
23. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK; Abbey M; Nestel PJ; Howe PR
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
[TBL] [Abstract][Full Text] [Related]
25. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
[TBL] [Abstract][Full Text] [Related]
26. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
27. Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics.
Legault L; Ogilvie RI; Cardella CJ; Leenen FH
Can J Cardiol; 1993 Jun; 9(5):398-404. PubMed ID: 8348391
[TBL] [Abstract][Full Text] [Related]
28. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
Taegtmeyer AB; Crook AM; Barton PJ; Banner NR
J Am Coll Cardiol; 2004 Sep; 44(6):1254-60. PubMed ID: 15364328
[TBL] [Abstract][Full Text] [Related]
29. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
Olivari MT; Antolick A; Ring WS
J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
[TBL] [Abstract][Full Text] [Related]
30. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
32. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
Nordøy A; Hansen JB; Brox J; Svensson B
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):7-16. PubMed ID: 11383326
[TBL] [Abstract][Full Text] [Related]
33. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
35. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
Dahlöf B
Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
Scherrer U; Vissing SF; Morgan BJ; Rollins JA; Tindall RS; Ring S; Hanson P; Mohanty PK; Victor RG
N Engl J Med; 1990 Sep; 323(11):693-9. PubMed ID: 2388667
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acids and blood pressure.
Cabo J; Alonso R; Mata P
Br J Nutr; 2012 Jun; 107 Suppl 2():S195-200. PubMed ID: 22591893
[TBL] [Abstract][Full Text] [Related]
38. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension.
Textor SC; Schwartz L; Wilson DJ; Wiesner R; Romero JC; Augustine J; Kos P; Hay E; Gores G; Dickson ER
Hypertension; 1994 Jan; 23(1 Suppl):I220-4. PubMed ID: 8282363
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation.
Kaye D; Thompson J; Jennings G; Esler M
Circulation; 1993 Sep; 88(3):1101-9. PubMed ID: 8394783
[TBL] [Abstract][Full Text] [Related]
40. Effects of successful cardiac transplantation on plasma endothelin.
Haas GJ; Wooding-Scott M; Binkley PF; Myerowitz PD; Kelley R; Cody RJ
Am J Cardiol; 1993 Jan; 71(2):237-40. PubMed ID: 8421989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
